Liquidia Corporation (LQDA)
NASDAQ: LQDA · Real-Time Price · USD
35.20
-0.30 (-0.85%)
At close: Mar 24, 2026, 4:00 PM EDT
35.70
+0.50 (1.42%)
After-hours: Mar 24, 2026, 7:42 PM EDT
Liquidia Market Cap
Liquidia has a market cap or net worth of $3.1 billion as of March 24, 2026. Its market cap has increased by 147.28% in one year.
Market Cap
3.10B
Enterprise Value
3.11B
1-Year Change
147.28%
Ranking
Category
Stock Price
$35.20
Market Cap Chart
Since July 26, 2018, Liquidia's market cap has increased from $167.77M to $3.10B, an increase of 1,748.69%. That is a compound annual growth rate of 46.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 23, 2026 | 3.13B | 4.25% |
| Dec 31, 2025 | 3.00B | 201.46% |
| Dec 31, 2024 | 995.33M | 20.97% |
| Dec 29, 2023 | 822.82M | 100.28% |
| Dec 30, 2022 | 410.83M | 62.30% |
| Dec 31, 2021 | 253.13M | 98.01% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jul 26, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Hims & Hers Health | 5.02B |
| Lantheus Holdings | 4.94B |
| Alkermes | 4.69B |
| Amneal Pharmaceuticals | 3.72B |
| Kiniksa Pharmaceuticals International, | 3.53B |
| Prestige Consumer Healthcare | 2.89B |
| Supernus Pharmaceuticals | 2.74B |
| BioCryst Pharmaceuticals | 2.43B |